| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6146542 | American Journal of Obstetrics and Gynecology | 2012 | 8 Pages |
Abstract
Incidence of neurodevelopmental impairment in children treated with intrauterine transfusion for fetal alloimmune anemia is low (4.8%). Prevention of fetal hydrops, the strongest preoperative predictor for impaired neurodevelopment, by timely detection, referral and treatment may improve long-term outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Irene T. MD, Vivianne E. MD, Jeanine M. MSc, Esther MD, Inge L. MD, PhD, Frans J. MD, PhD, Henk MD, PhD, Ilias I. MD, PhD, Humphrey H. MD, PhD, Jan M. MD, PhD, Erik W. MD, PhD, Dick MD, PhD, Anneke MD, PhD, Enrico MD, PhD,